Evidence that high peripheral cholesterol levels are associated with increased risk of AD and that statins, which reduce circulating cholesterol by inhibiting the cholesterol-synthesising enzyme HMG-CoA reductase, may reduce risk for AD [77] might seem to contradict the hypothesis presented here. The gene discussed is HMGCR; the disease is Alzheimer disease.